What format is required for submitting sequence listings in provisional applications filed on or after July 1, 2022?
For provisional applications filed on or after July 1, 2022, if an applicant chooses to submit nucleotide and/or amino acid sequence data, it must be in a specific format. The MPEP states: if submitted in a provisional application filed on or after July 1, 2022, any submission of nucleotide and/or amino acid sequence data must…
Read MoreHow should a Sequence Listing be formatted?
A Sequence Listing must be formatted according to specific standards set by the USPTO. As stated in MPEP 2421.01: 37 CFR 1.821(c) requires that applications containing disclosures of nucleotide and/or amino acid sequences that fall within the definitions of 37 CFR 1.821(a) contain, as a separate part, a disclosure of the nucleotide and/or amino acid…
Read MoreWhat is the proper format for presenting sequences in a patent application?
What is the proper format for presenting sequences in a patent application? The proper format for presenting sequences in a patent application is outlined in MPEP 2423.01 and follows the WIPO Standard ST.25. Key points include: Use a fixed-width font (e.g., Courier) in 10 point or larger size Present sequences with a maximum of 60…
Read More